S.N. Vyshelesski Institute of Experimental Veterinary

220063, Briketa ul., 28, Мinsk, Belarus Тel./fax: +375 17 517 32 61 E-mail: bievm@tut.by

Vaccine "BELRAB" anti-rabies inactivated from strain 71 BelNIIEV-VGNKI









Linked profile in other language
Alla Larkova
S.N. Vyshelesski Institute of Experimental Veterinary offers consumers a vaccine "BELRAB" anti-rabies inactivated from strain 71 BelNIIEV-VGNKIunder under a manufacturing agreement and is looking for partners interested in a distribution services agreement.
The vaccine is intended for immunization of domestic and farm animals (cattle and small cattle, horses, camels, pigs, dogs and cats) against rabies in farms and areas that are threatened and unaffected by this disease.

A homogeneous suspension with a loose sediment, which, when shaken, breaks into a uniform suspension and acquires a color from beige to white-pink in various shades.

The vaccine is made from the rabies virus strain "71 BelNIIEV-VGNKI", inactivated with theotropine or another inactivant with the addition of aluminum hydroxide as an adjuvant. The virus is cultivated in Syrian hamster kidney (BHK-21) or green monkey kidney (Vero) cell cultures.
The vaccine causes the production of specific antibodies in animals and provides immune protection against rabies.

For preventive immunization of animals vaccinated against rabies for the first time, the vaccine is administered twice with an interval of 20-30 days. Animals previously vaccinated against rabies are given the vaccine once. Revaccination is carried out after a year.

The vaccine is administered subcutaneously in the neck or intramuscularly in the thigh. Before use, shake the vaccine until a homogeneous suspension is formed.

The vaccine is administered in the following volume (per infection):
- puppies two months of age and older and adult dogs of small decorative breeds (lapdogs, dachshunds, spitz, terriers, etc.), as well as cats - 1.0 cubic cm.
- dogs of large breeds (shepherds, St. Bernards, etc.) weighing over 10 kg - 1.5 cubic cm.
- small cattle and pigs - 1.5 cubic cm.
- cattle, horses, camels and other large animals - 3.0
Forced vaccination is carried out no later than 72 hours after possible infection of the animal. In this case, the vaccine is administered to the animal four times in the above doses for three days in a row with a distant injection 16 days from the start of immunization.
Animals with clinical signs or suspected of having rabies are prohibited from receiving the vaccine. Immunized animals are monitored for one month.

Milk and slaughter products from immunized farm animals are used without restrictions.

Sterile glass vials 1.0 each; 2.0; 4.0; 8.0; 10.0; 20.0; 50.0; 100.0 and 200.0 cubic cm. closed with a rubber stopper and rolled in aluminum caps.

The shelf life of the drug is 18 months from the date of manufacture, provided it is stored in a dry place protected from light at a temperature of plus 2 to plus 8 ° C.

More details on the institute's website (in Russian).
Advantages and Innovations
Vaccines and drugs were developed and tested by the Institute’s staff, and also tested in accredited laboratories.
Stage of development
Already on the market
Funding source
State budged
IPR status
Exclusive rights
Secret know-how
Sector group

Organization information

R&D institution
Year established
NACE keywords
A.01.61 - Support activities for crop production
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Turnover (in EUR)
Already engaged in transnational cooperation
Additional comments
The high level of development of animal husbandry in the Republic of Belarus is largely ensured by the efforts of veterinary medicine and its scientific and methodological center, which is the Republican Unitary Enterprise “S.N. Vyshelesski Institute of Experimental Veterinary".

Areas of activity of the Institute:
✔ development and improvement of methods for diagnosis, prevention, treatment, measures to combat infectious, parasitic and non-contagious diseases of farm animals, birds, bees;
✔ creation of modern vaccines, highly specific diagnostics, drugs, metabolic correction agents that provide veterinary protection of animals and obtain environmentally friendly livestock products;
✔ provision of scientific and practical assistance to the farms of the republic;
✔ training of highly qualified scientific personnel.

The tasks facing the Institute:
✔ conducting fundamental and applied research in the field of veterinary medicine in accordance with the main directions of economic and social development of the agro-industrial complex of the Republic of Belarus;
✔ conducting fundamental and applied research to study the mechanisms of immunity formation and the development of methods for its directed regulation;
✔ development of forecasts and programs for veterinary medicine;
✔ epizootological monitoring of the most common and parasitic infectious animal diseases, development of short-term and long-term forecasts of their occurrence and degree of manifestation;
✔ development of new and improvement of existing competitive means and methods for the diagnosis, prevention and treatment of infectious, parasitic and non-contagious animal diseases, the creation of integrated systems that ensure the protection of human health, the veterinary welfare of animal husbandry, obtaining environmentally friendly and high sanitary quality livestock products;
✔ isolation and study of the genetic, molecular and biological properties of pathogens of infectious diseases, selection and collection of useful strains that are promising for the creation of diagnosticums and vaccines;
✔ development of technologies for the production of veterinary drugs, vaccines, chemicals, antiparasitic agents.
Languages spoken

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing the BELRAB inactivated rabies vaccine from strain 71 BelNIIEV-VGNKI under a manufacturing agreement.

Partners interested in purchasing the BELRAB inactivated rabies vaccine from strain 71 BelNIIEV-VGNKI under a distribution services agreement.
Type and size of partner sought
> 500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
Sole proprietor


Views: 316
Statistics since 08.12.2023 12:38:12